GSK

BEXSERO

Manufacturer:

GSK

Bexsero HCPCS:

90620

HCPCS Code Descriptor:

Meningococcal recombinant protein and outer membrane vesicle vaccine, serogroup B (MenB-4C), 2 dose schedule, for intramuscular use

Category:

CPT Drug Code

Bexsero NDCs:

58160-0976-20

Primary Type:

Vaccine-Meningococcal

Generic/Specialty Status:

Single-Source

Route of Administration:

Intramuscular

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

58160-0976-20

About Bexsero:

BEXSERO is a Vaccine-Meningococcal drug manufactured by GSK and administered via the Intramuscular route of administration. The CPT Drug Code: 90620 is aligned to the drug BEXSERO.

ACCESS PRICING AND MORE BY REGISTERING

90620 Added Date:

NA

90620 Effective Date:

NA

90620 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Bexsero billing and coding information.
Our team did not identify a source for Bexsero patient assistance information. Please reach out to our team if you feel that this is a mistake.
BEXSERO prescribing information can be found at the link below:
Information regarding BEXSERO’s side effects can be found at MedlinePlus